The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil

Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19. Methods We carried out an analysis of all pediatric patients 2–19 years of...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric pulmonology Vol. 58; no. 3; pp. 727 - 737
Main Authors: Oliveira, Maria C. L., Colosimo, Enrico A., Vasconcelos, Mariana A., Martelli‐Júnior, Hercílio, Mak, Robert H., Silva, Ludmila R., Pinhati, Clara C., Simões e Silva, Ana C., Oliveira, Eduardo A.
Format: Journal Article
Language:English
Published: United States Wiley Subscription Services, Inc 01-03-2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19. Methods We carried out an analysis of all pediatric patients 2–19 years of age with asthma and COVID‐19 registered in Influenza Epidemiological Surveillance Information System‐Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. Results Among 30,405 hospitalized children with COVID‐19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29–0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in‐hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5–6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4–3.2). Conclusion Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors.
AbstractList There have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID-19. We carried out an analysis of all pediatric patients 2-19 years of age with asthma and COVID-19 registered in Influenza Epidemiological Surveillance Information System-Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. Among 30,405 hospitalized children with COVID-19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29-0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in-hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5-6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4-3.2). Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors.
Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID‐19. Methods We carried out an analysis of all pediatric patients 2–19 years of age with asthma and COVID‐19 registered in Influenza Epidemiological Surveillance Information System‐Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. Results Among 30,405 hospitalized children with COVID‐19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29–0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in‐hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5–6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4–3.2). Conclusion Children with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors.
OBJECTIVEThere have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with asthma and healthy peers hospitalized due to COVID-19. METHODSWe carried out an analysis of all pediatric patients 2-19 years of age with asthma and COVID-19 registered in Influenza Epidemiological Surveillance Information System-Gripe, a Brazilian nationwide surveillance database, between February 2020 and March 2022. The primary outcome was time to death, which was evaluated considering discharge as a competitive risk using the cumulative incidence function. RESULTSAmong 30,405 hospitalized children with COVID-19, 21,340 (70.2%) had no comorbidities, 6444 (21.2%) had comorbidities other than asthma, 2165 (7.1%) had asthma, and 465 (1.5%) had asthma with other comorbidities. The estimated probability of a fatal outcome for each group was 4.1%, 14.9%, 2.1%, and 10.7%, respectively. After adjustment, children with asthma had a 60% reduction in the hazard of death than healthy peers (hazard ratio [HR] = 0.39, 95% confidence interval [CI], 0.29-0.53, p < 0.0001). Among children with asthma and no other comorbidities, two covariates were independently associated with in-hospital mortality, age ≥12 years, HR = 4.0, 95% CI, 2.5-6.4), and low oxygen saturation at admission (HR = 2.3, 95% CI, 1.4-3.2). CONCLUSIONChildren with asthma and no comorbidities had a lower risk of death compared with healthy peers after controlling for clinical and demographic confounding factors.
Author Martelli‐Júnior, Hercílio
Vasconcelos, Mariana A.
Simões e Silva, Ana C.
Mak, Robert H.
Colosimo, Enrico A.
Silva, Ludmila R.
Oliveira, Maria C. L.
Pinhati, Clara C.
Oliveira, Eduardo A.
Author_xml – sequence: 1
  givenname: Maria C. L.
  surname: Oliveira
  fullname: Oliveira, Maria C. L.
  organization: Federal University of Minas Gerais (UFMG)
– sequence: 2
  givenname: Enrico A.
  surname: Colosimo
  fullname: Colosimo, Enrico A.
  organization: Federal University of Minas Gerais
– sequence: 3
  givenname: Mariana A.
  surname: Vasconcelos
  fullname: Vasconcelos, Mariana A.
  organization: Federal University of Minas Gerais (UFMG)
– sequence: 4
  givenname: Hercílio
  surname: Martelli‐Júnior
  fullname: Martelli‐Júnior, Hercílio
  organization: State University of Montes Claros (Unimontes)
– sequence: 5
  givenname: Robert H.
  surname: Mak
  fullname: Mak, Robert H.
  organization: University of California, San Diego
– sequence: 6
  givenname: Ludmila R.
  surname: Silva
  fullname: Silva, Ludmila R.
  organization: Federal University of Minas Gerais (UFMG)
– sequence: 7
  givenname: Clara C.
  surname: Pinhati
  fullname: Pinhati, Clara C.
  organization: Federal University of Minas Gerais (UFMG)
– sequence: 8
  givenname: Ana C.
  surname: Simões e Silva
  fullname: Simões e Silva, Ana C.
  organization: Federal University of Minas Gerais (UFMG)
– sequence: 9
  givenname: Eduardo A.
  orcidid: 0000-0002-5642-7164
  surname: Oliveira
  fullname: Oliveira, Eduardo A.
  email: eduolive812@gmail.com
  organization: Federal University of Minas Gerais (UFMG)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36382503$$D View this record in MEDLINE/PubMed
BookMark eNp90c1u1DAUBWALtaLTwoYHQJbYoEpp7Ti24yUd_iqN1C5atpHHviEuiR3sREO76gsg8Yw8CR6mdNEFq7vwd4-vdA7Rng8eEHpFyQklpDwdx7k_KUVZ8WdoQYlSBamU2EOLWnJeiFqwA3SY0g0h-U3R5-iACVaXnLAF-nnVAdYpBeP05ILHa5g2AB6PEX7f_4IfLk3Of81k6gaNtbc4gp0N5OnSNxxabEFPHdZDyMx0rrcxr2-htqGHZMBPCXchjW7SvbvLmxuXF5YXX87f5y-ows7js6jvXP8C7be6T_DyYR6h648frpafi9XFp_Plu1VhGJe8oKw1ylij2lZxUhJZGSoqLhXVa0rAKlVSSzkXXLQls1CVVldGMVMrIypg7Ai93eWOMXyfIU3N4PKhfa89hDk1pWSS0ppSmembJ_QmzNHn67KSQomKSJrV8U6ZGFKK0DZjdIOOtw0lzbakZltS87ekjF8_RM7rAewj_ddKBnQHNq6H2_9ENZeX16td6B-jV6Ds
CitedBy_id crossref_primary_10_3389_fimmu_2023_1217181
crossref_primary_10_1093_jpids_piae052
Cites_doi 10.1016/j.jaci.2020.08.008
10.1080/02770903.2021.1888116
10.1002/ppul.24909
10.1111/cea.14021
10.1016/j.jaci.2020.04.061
10.1097/INF.0000000000003043
10.1186/s12948-021-00159-4
10.1016/S2213-2600(21)00491-4
10.1542/peds.2021-056164
10.1080/01621459.1999.10474144
10.1007/s00467-022-05588-0
10.1183/13993003.02226-2020
10.1111/all.14426
10.1007/s00408-021-00419-9
10.1002/ppul.26132
10.1002/ppul.25937
10.1111/pai.13696
10.1038/s41586-020-2521-4
10.1002/ppul.25117
10.1111/ijpo.12920
10.1016/j.jpeds.2022.01.001
10.1002/ppul.26091
10.1016/j.anai.2020.07.029
10.1016/j.anai.2022.03.017
10.1136/thoraxjnl-2021-218629
10.1016/S2352-4642(21)00277-7
10.1002/ppul.26065
10.1016/j.jpeds.2022.02.048
10.1111/pedi.13335
10.1111/all.14480
10.1016/j.ccc.2021.05.003
10.1159/000518896
10.1016/S2352-4642(21)00134-6
10.1002/sim.2712
10.3389/fimmu.2022.705379
10.1016/j.resinv.2019.12.005
10.1590/S0021-75572006000600006
10.1002/ppul.26184
10.1542/peds.2021-055765
10.1016/j.pcl.2021.05.012
ContentType Journal Article
Copyright 2022 Wiley Periodicals LLC.
2023 Wiley Periodicals LLC.
Copyright_xml – notice: 2022 Wiley Periodicals LLC.
– notice: 2023 Wiley Periodicals LLC.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
K9.
7X8
DOI 10.1002/ppul.26245
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1099-0496
EndPage 737
ExternalDocumentID 10_1002_ppul_26245
36382503
PPUL26245
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Brazil
GeographicLocations_xml – name: Brazil
GrantInformation_xml – fundername: Conselho Nacional de Desenvolvimento Científico e Tecnológico
– fundername: Fundação de Amparo à Pesquisa do Estado de Minas Gerais
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPPZ
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
DUUFO
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
TEORI
UB1
V2E
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XPP
XV2
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
K9.
7X8
ID FETCH-LOGICAL-c3575-13fc9cdc9ff9502074c1645791ab10ed9921d155656f23de42da4c93c89c64e33
IEDL.DBID 33P
ISSN 8755-6863
IngestDate Fri Aug 16 04:43:30 EDT 2024
Thu Oct 10 20:42:08 EDT 2024
Thu Nov 21 21:36:55 EST 2024
Sat Sep 28 08:15:36 EDT 2024
Sat Aug 24 01:12:04 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords COVID-19
SARS-CoV-2
risk factors
asthma
children
outcome
Language English
License 2022 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3575-13fc9cdc9ff9502074c1645791ab10ed9921d155656f23de42da4c93c89c64e33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-5642-7164
PMID 36382503
PQID 2776964071
PQPubID 1036356
PageCount 11
ParticipantIDs proquest_miscellaneous_2737118117
proquest_journals_2776964071
crossref_primary_10_1002_ppul_26245
pubmed_primary_36382503
wiley_primary_10_1002_ppul_26245_PPUL26245
PublicationCentury 2000
PublicationDate March 2023
2023-03-00
20230301
PublicationDateYYYYMMDD 2023-03-01
PublicationDate_xml – month: 03
  year: 2023
  text: March 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Pediatric pulmonology
PublicationTitleAlternate Pediatr Pulmonol
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2021; 68
2021; 5
2022; 23
2020; 58
2020; 584
2020; 55
2020; 146
2020; 125
2021; 57
2022; 101
2022; 244
2006; 82
2021; 59
2021; 37
2021; 76
2022
2021; 19
2022; 57
2022; 13
2022; 52
2022; 10
2021; 199
1999; 94
2022; 33
2022; 129
2021; 40
2022; 149
2022; 17
2022; 245
2007; 26
e_1_2_9_30_1
e_1_2_9_31_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_19_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_20_1
e_1_2_9_40_1
e_1_2_9_22_1
e_1_2_9_21_1
e_1_2_9_24_1
e_1_2_9_23_1
e_1_2_9_8_1
e_1_2_9_7_1
e_1_2_9_6_1
e_1_2_9_5_1
e_1_2_9_4_1
e_1_2_9_3_1
e_1_2_9_2_1
e_1_2_9_9_1
e_1_2_9_26_1
e_1_2_9_25_1
e_1_2_9_28_1
e_1_2_9_27_1
e_1_2_9_29_1
References_xml – volume: 68
  start-page: 1119
  issue: 5
  year: 2021
  end-page: 1131
  article-title: The impact of coronavirus disease 2019 on pediatric asthma in the United States
  publication-title: Pediatr Clin North Am
– volume: 10
  start-page: 191
  issue: 2
  year: 2022
  end-page: 198
  article-title: Risk of COVID‐19 hospital admission among children aged 5–17 years with asthma in Scotland: a national incident cohort study
  publication-title: Lancet Resp Med
– volume: 94
  start-page: 496
  year: 1999
  end-page: 509
  article-title: A proportional hazards model for the sub‐distribution of a competing risk
  publication-title: J Am Stat Assoc
– volume: 146
  start-page: 334
  issue: 2
  year: 2020
  end-page: 335
  article-title: Prevalence of comorbid asthma in COVID‐19 patients
  publication-title: J Allergy Clin Immunol
– volume: 584
  start-page: 430
  issue: 7821
  year: 2020
  end-page: 436
  article-title: Factors associated with COVID‐19‐related death using OpenSAFELY
  publication-title: Nature
– volume: 5
  start-page: e40
  issue: 10
  year: 2021
  end-page: e42
  article-title: Risk factors for COVID‐19 mortality in hospitalised children and adolescents in Brazil—authors' reply
  publication-title: Lancet Child Adolescent Health
– volume: 199
  start-page: 7
  issue: 1
  year: 2021
  end-page: 12
  article-title: COVID‐19 in children with asthma
  publication-title: Lung
– year: 2022
  article-title: Asthma as a comorbidity in COVID‐19 pediatric ICU admissions in a large metropolitan children's hospital
  publication-title: Pediatr Pulmonol
– volume: 5
  start-page: 559
  issue: 8
  year: 2021
  end-page: 568
  article-title: Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID‐19 in Brazil: an analysis of a nationwide database
  publication-title: Lancet Child Adolescent Health
– volume: 52
  start-page: 7
  issue: 1
  year: 2022
  end-page: 9
  article-title: Hypotheses to explain the associations between asthma and the consequences of COVID‐19 infection
  publication-title: Clin Exp Allergy
– volume: 76
  start-page: 866
  issue: 3
  year: 2021
  end-page: 868
  article-title: Is asthma protective against COVID‐19
  publication-title: Allergy
– volume: 58
  start-page: 155
  issue: 3
  year: 2020
  end-page: 168
  article-title: Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV‐229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells
  publication-title: Resp Investig
– volume: 55
  start-page: 2412
  issue: 9
  year: 2020
  end-page: 2418
  article-title: Asthma and COVID‐19 in children: a systematic review and call for data
  publication-title: Pediatr Pulmonol
– volume: 57
  start-page: 3044
  issue: 12
  year: 2022
  end-page: 3049
  article-title: Clinical presentation and outcomes of hospitalized children with COVID‐19 in Mexico City
  publication-title: Pediatr Pulmonol
– volume: 19
  start-page: 19
  issue: 1
  year: 2021
  article-title: The potential protective role of corticosteroid therapy in patients with asthma and COPD against COVID‐19
  publication-title: Clin Mol Allergy
– volume: 245
  start-page: 102
  year: 2022
  end-page: 110
  article-title: Comorbidities associated with hospitalization and progression among adolescents with symptomatic coronavirus disease 2019
  publication-title: J Pediatr
– volume: 23
  start-page: 763
  issue: 6
  year: 2022
  end-page: 772
  article-title: Risk factors for COVID‐19‐related mortality in hospitalized children and adolescents with diabetes mellitus: an observational retrospective cohort study
  publication-title: Pediatr Diabetes
– volume: 33
  issue: 1
  year: 2022
  article-title: Asthma as a risk factor for hospitalization in children with COVID‐19: a nested case‐control study
  publication-title: Pediatr Allergy Immunol
– volume: 40
  start-page: e137
  issue: 4
  year: 2021
  end-page: e145
  article-title: Risk factors for severe COVID‐19 in children
  publication-title: Pediatr Infect Dis J
– volume: 55
  start-page: 3573
  issue: 12
  year: 2020
  end-page: 3578
  article-title: Pediatric asthma and COVID‐19: the known, the unknown, and the controversial
  publication-title: Pediatr Pulmonol
– volume: 57
  start-page: 1693
  issue: 7
  year: 2022
  end-page: 1700
  article-title: Comparison of clinical features of COVID‐19 infection in children with asthma and their healthy peers
  publication-title: Pediatr Pulmonol
– volume: 17
  issue: 9
  year: 2022
  article-title: Outcomes and risk factors of death among hospitalized children and adolescents with obesity and COVID‐19 in Brazil: an analysis of a nationwide database
  publication-title: Pediatr Obes
– volume: 76
  start-page: 565
  issue: 2
  year: 2021
  end-page: 567
  article-title: COVID‐19 and asthma, the good or the bad?
  publication-title: Allergy
– volume: 101
  start-page: 307
  issue: 3
  year: 2022
  end-page: 320
  article-title: Risk assessment for patients with chronic respiratory conditions in the context of the SARS‐CoV‐2 pandemic statement of the German respiratory society with the support of the German association of chest physicians
  publication-title: Respiration
– volume: 59
  start-page: 866
  year: 2021
  end-page: 879
  article-title: Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID‐19: systematic review and meta‐analysis
  publication-title: J Asthma
– volume: 149
  issue: 6
  year: 2022
  article-title: Asthma and the risk of SARS‐CoV‐2 infection among children and adolescents
  publication-title: Pediatrics
– volume: 129
  start-page: 79
  issue: 1
  year: 2022
  end-page: 87
  article-title: Asthma and coronavirus disease 2019–related outcomes in hospitalized patients
  publication-title: Ann Allergy Asthma Immunol
– volume: 125
  start-page: 707
  issue: 6
  year: 2020
  end-page: 709
  article-title: Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia
  publication-title: Ann Allergy Asthma Immunol
– volume: 13
  year: 2022
  article-title: Causal association and shared genetics between asthma and COVID‐19
  publication-title: Front Immunol
– volume: 146
  start-page: 790
  issue: 4
  year: 2020
  end-page: 798
  article-title: Allergic disorders and susceptibility to and severity of COVID‐19: a nationwide cohort study
  publication-title: J Allergy Clin Immunol
– volume: 37
  start-page: 749
  issue: 4
  year: 2021
  end-page: 776
  article-title: Pathophysiology of acute respiratory distress syndrome and COVID‐19 lung injury
  publication-title: Crit Care Clin
– year: 2022
  article-title: Relationship between asthma and severe COVID‐19: a national cohort study
  publication-title: Thorax
– volume: 149
  issue: 4
  year: 2022
  article-title: Severity of acute COVID‐19 in children <18 years old March 2020 to December 2021
  publication-title: Pediatrics
– volume: 82
  start-page: 341
  issue: 5
  year: 2006
  end-page: 346
  article-title: Prevalence of symptoms of asthma, rhinitis, and atopic eczema among Brazilian children and adolescents identified by the international study of asthma and allergies in childhood (ISAAC)—phase 3
  publication-title: J Pediatr
– volume: 244
  start-page: 178
  year: 2022
  end-page: 185
  article-title: Comparison of the first and second waves of the coronavirus disease 2019 pandemic in children and adolescents in a Middle‐Income country: clinical impact associated with severe acute respiratory syndrome coronavirus 2 gamma lineage
  publication-title: J Pediatr
– volume: 26
  start-page: 2389
  issue: 11
  year: 2007
  end-page: 2430
  article-title: Tutorial in biostatistics: competing risks and multi‐state models
  publication-title: Stat Med
– volume: 57
  start-page: 2491
  year: 2022
  end-page: 2501
  article-title: The prevalence and associated factors of asthma, allergic rhinitis, and eczema in Turkish children and adolescents
  publication-title: Pediatr Pulmonol
– volume: 57
  issue: 3
  year: 2021
  article-title: Effect of asthma and asthma medication on the prognosis of patients with COVID‐19
  publication-title: Eur Respir J
– volume: 57
  start-page: 2855
  issue: 11
  year: 2022
  end-page: 2860
  article-title: Asthma 17q21 polymorphism associates with decreased risk of COVID‐19 in children
  publication-title: Pediatr Pulmonol
– year: 2022
  article-title: Outcomes and risk factors for death among hospitalized children and adolescents with kidney diseases and COVID‐19: an analysis of a nationwide database
  publication-title: Pediatr Nephrol
– ident: e_1_2_9_7_1
  doi: 10.1016/j.jaci.2020.08.008
– ident: e_1_2_9_8_1
  doi: 10.1080/02770903.2021.1888116
– ident: e_1_2_9_18_1
  doi: 10.1002/ppul.24909
– ident: e_1_2_9_31_1
  doi: 10.1111/cea.14021
– ident: e_1_2_9_38_1
  doi: 10.1016/j.jaci.2020.04.061
– ident: e_1_2_9_29_1
  doi: 10.1097/INF.0000000000003043
– ident: e_1_2_9_37_1
  doi: 10.1186/s12948-021-00159-4
– ident: e_1_2_9_16_1
  doi: 10.1016/S2213-2600(21)00491-4
– ident: e_1_2_9_17_1
  doi: 10.1542/peds.2021-056164
– ident: e_1_2_9_23_1
  doi: 10.1080/01621459.1999.10474144
– ident: e_1_2_9_27_1
  doi: 10.1007/s00467-022-05588-0
– ident: e_1_2_9_6_1
  doi: 10.1183/13993003.02226-2020
– ident: e_1_2_9_32_1
  doi: 10.1111/all.14426
– ident: e_1_2_9_39_1
  doi: 10.1007/s00408-021-00419-9
– ident: e_1_2_9_24_1
  doi: 10.1002/ppul.26132
– ident: e_1_2_9_14_1
  doi: 10.1002/ppul.25937
– ident: e_1_2_9_28_1
  doi: 10.1111/pai.13696
– ident: e_1_2_9_3_1
  doi: 10.1038/s41586-020-2521-4
– ident: e_1_2_9_5_1
  doi: 10.1002/ppul.25117
– ident: e_1_2_9_26_1
  doi: 10.1111/ijpo.12920
– ident: e_1_2_9_20_1
  doi: 10.1016/j.jpeds.2022.01.001
– ident: e_1_2_9_34_1
  doi: 10.1002/ppul.26091
– ident: e_1_2_9_12_1
  doi: 10.1016/j.anai.2020.07.029
– ident: e_1_2_9_10_1
  doi: 10.1016/j.anai.2022.03.017
– ident: e_1_2_9_11_1
  doi: 10.1136/thoraxjnl-2021-218629
– ident: e_1_2_9_19_1
  doi: 10.1016/S2352-4642(21)00277-7
– ident: e_1_2_9_15_1
  doi: 10.1002/ppul.26065
– ident: e_1_2_9_4_1
  doi: 10.1016/j.jpeds.2022.02.048
– ident: e_1_2_9_25_1
  doi: 10.1111/pedi.13335
– ident: e_1_2_9_35_1
  doi: 10.1111/all.14480
– ident: e_1_2_9_40_1
  doi: 10.1016/j.ccc.2021.05.003
– ident: e_1_2_9_13_1
  doi: 10.1159/000518896
– ident: e_1_2_9_21_1
  doi: 10.1016/S2352-4642(21)00134-6
– ident: e_1_2_9_22_1
  doi: 10.1002/sim.2712
– ident: e_1_2_9_33_1
  doi: 10.3389/fimmu.2022.705379
– ident: e_1_2_9_36_1
  doi: 10.1016/j.resinv.2019.12.005
– ident: e_1_2_9_41_1
  doi: 10.1590/S0021-75572006000600006
– ident: e_1_2_9_9_1
  doi: 10.1002/ppul.26184
– ident: e_1_2_9_30_1
  doi: 10.1542/peds.2021-055765
– ident: e_1_2_9_2_1
  doi: 10.1016/j.pcl.2021.05.012
SSID ssj0009991
Score 2.4386191
Snippet Objective There have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among...
There have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among children with...
ObjectiveThere have been conflicting reports on the relationship between asthma and COVID‐19 severity. This study aimed to compare the risk of death among...
OBJECTIVEThere have been conflicting reports on the relationship between asthma and COVID-19 severity. This study aimed to compare the risk of death among...
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 727
SubjectTerms Adolescent
Asthma
Asthma - epidemiology
Brazil - epidemiology
Child
children
Comorbidity
COVID-19
COVID-19 - epidemiology
Hospitalization
Humans
outcome
risk factors
SARS-CoV-2
Title The association between pre‐existing asthma and reduced risk of death among children and adolescents hospitalized with COVID‐19 in Brazil
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fppul.26245
https://www.ncbi.nlm.nih.gov/pubmed/36382503
https://www.proquest.com/docview/2776964071
https://search.proquest.com/docview/2737118117
Volume 58
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JSwMxFA7ag3hxX-pGRE_CaCfJZCbgxRUFl4IL3oZMFlrUaWntpSf_gOBv9Jf4kpm2iiCIpwnMCwl5eXlflvc9hLZrxhqWhDaQkVIB40QEGewaAg3eHLxJknGfi-DsJr56SI5PHE3O_iAWpuCHGB64Ocvw67UzcJl190akoe1272mXcMJchDlsE3z8Bq2PGHeFT5cHeDwKeMLpkJuU7I2qfvdGPyDmd8TqXc7p9P86O4OmSqiJD4q5MYvGTD6HJi7Ly_R59AZTBMuRenD5Zgu3O-bj9d1xZLo30SDy0niWWOYadxzRq4Fvs_uIWxZrByCxT1iEB2HhXvALURRulKlJmn2o6c598dH1_fkxNBEK3MzxYUf2m08L6O705PboLCizMwSKAsYLQmqVUFoJa0UEoDNmCrZeUSxCmYU1o4UgoQa0AoDREqoNI1oyJahKhOLMULqIKnkrN8sIRyKxmmtKGYuYqWUZ1wZwodTCypphtIq2BlpK2wUJR1rQLZPUjWzqR7aK1gYKTEtD7KYkjrlwl5VhFW0Of4MJuXsRmZtWz8nQ2MXfhnEVLRWKHzZDYX0ClAhd2PH6_aX9tF6_u_Cllb8Ir6JJl8K-eNe2hiovnZ5ZR-Nd3dvwE_oTKp_6Qw
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LbxMxEB7RIlEu5VVoSilG5YS0Tdb2etcHDpC2SkRaIrVF3FZeP5SIdBMlzaUn_gBSf2N_CWPvJqFCQqo47Uo7lleeGc_nx3wD8L5lneVZ7CKVaB1xQWVU4KohMhjNMZpkhQi1CDpn6en37PDI0-R8XOTCVPwQyw037xlhvvYO7jekmyvW0MlkPjqggvJkDR5ygZboMzhYf8W5K0PBPETkSSQywZbspLS5ans3Hv0FMu9i1hB0jp_85-8-hc0abZJPlXk8gwe2fA6PTurz9BfwC62EqJWGSH1ti0ym9vbnjafJ9NeiUeRqcKmIKg2Zeq5Xi8_h7AcZO2I8hiShZhFZZIYHwT-4osigrk4yvMaWfuuXtL9-6x5iF7Ekw5J8nqrr4WgLLo6PztudqC7QEGmGMC-KmdNSGy2dkwnizpRrXH0lqYxVEbeskZLGBgELYkZHmbGcGsW1ZDqTWnDL2EtYL8el3QaSyMwZYRjjPOG2VRTCWISGykinWpazBuwv1JRPKh6OvGJcprkf2TyMbAN2FxrMa1-c5TRNhfTnlXED3i0_oxf5oxFV2vHcy7DUp-DGaQNeVZpfdsNwikKgiL_wISj4H_3n_f5FL7zt3Ef4LWx0zk96ea97-uU1PPYV7atrbruwfjWd2zewNjPzvWDdvwHr6f5r
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bSxwxFD54AemL1l50vTWlfSqM7iSZzAT60rouSq1dUItvQyYXXNTZYdd98ck_UOhv9Jd4kpndVQqF0qcJzAkJOTk5X3KS7wB8bFtneRa7SCVaR1xQGRW4a4gMenP0JlkhQi6Cw9P05CLrHHianM-TtzA1P8T0wM1bRlivvYFXxu3NSEOrany9SwXlyTwscsThnjmfsd6McleGfHkIyJNIZIJNyUnp3qzuc3f0B8Z8DlmDz-mu_F9vX8JygzXJl3pyrMKcLV_B0vcmmv4afuEcIWqmH9Jc2iLV0D7c__Ykmf5SNIrcXt4ookpDhp7p1eK3P7oiA0eMR5AkZCwik3fhQfAJUxS5bHKT9O-wpj_4Jfs_fh51sIlYkn5Jvg7VXf_6DZx3D872D6MmPUOkGYK8KGZOS220dE4miDpTrnHvlaQyVkXctkZKGhuEK4gYHWXGcmoU15LpTGrBLWNvYaEclHYdSCIzZ4RhjPOE23ZRCGMRGCojnWpbzlrwYaKlvKpZOPKab5nmfmTzMLIt2JooMG8scZTTNBXSRyvjFryf_kYb8oERVdrB2Muw1D_AjdMWrNWKnzbDcIFCmIhd-BT0-5f2817v_DiUNv5F-B0s9Trd_Pjo5NsmvPDp7Os7bluwcDsc222YH5nxTpjbj96b_RE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+pre%E2%80%90existing+asthma+and+reduced+risk+of+death+among+children+and+adolescents+hospitalized+with+COVID%E2%80%9019+in+Brazil&rft.jtitle=Pediatric+pulmonology&rft.au=Oliveira%2C+Maria+C.+L.&rft.au=Colosimo%2C+Enrico+A.&rft.au=Vasconcelos%2C+Mariana+A.&rft.au=Martelli%E2%80%90J%C3%BAnior%2C+Herc%C3%ADlio&rft.date=2023-03-01&rft.issn=8755-6863&rft.eissn=1099-0496&rft.volume=58&rft.issue=3&rft.spage=727&rft.epage=737&rft_id=info:doi/10.1002%2Fppul.26245&rft.externalDBID=10.1002%252Fppul.26245&rft.externalDocID=PPUL26245
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=8755-6863&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=8755-6863&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=8755-6863&client=summon